Kung Winston (CIK 1666963) reported 5 SEC Form 4 insider transactions across 2 companies over the past 18 months (most recent 2026-06-12). Recent activity: Buy JANX (5,500 shares), Sell CRBP (2,026 shares), Buy CRBP (3,800 shares), Buy JANX (3,750 shares), Buy CRBP (4,800 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-06-12 | Janux Therapeutics, Inc. (JANX) | Director | Buy | 5,500 | $0 |
| 2026-06-11 | Corbus Pharmaceuticals Holdings, Inc. (CRBP) | Director | Sell | 2,026 | $16,033 |
| 2026-05-21 | Corbus Pharmaceuticals Holdings, Inc. (CRBP) | Director | Buy | 3,800 | $0 |
| 2025-06-13 | Janux Therapeutics, Inc. (JANX) | Director | Buy | 3,750 | $0 |
| 2025-06-02 | Corbus Pharmaceuticals Holdings, Inc. (CRBP) | Director | Buy | 4,800 | $0 |
Source: SEC Form 4 filings · as of 2026-06-12